Immunohelix
Specializes in immuno-modulation through targeted delivery of oligonucleotide drugs to antigen presenting cells, focusing on developing an innovative anti-GVHD treatment for hematopoietic stem cell transplantation in hematological cancers.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
